D
Centessa Pharmaceuticals plc CNTA
$16.51 -$0.495-2.91% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 6.69% -8.22% 11.30% 4.02% -16.34%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 24.27% 26.84% 77.44% 15.41% -6.46%
Operating Income -24.27% 14.72% -112.01% -15.41% 6.46%
Income Before Tax -14.97% 34.15% -208.97% -1.17% 11.91%
Income Tax Expenses 10.35% 190.44% -8.22% 121.51% 102.93%
Earnings from Continuing Operations -14.90% 31.31% -202.22% -10.14% -76.07%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -14.90% 31.31% -202.22% -10.14% -76.07%
EBIT -24.27% 14.72% -112.01% -15.41% 6.46%
EBITDA -24.42% 14.76% -112.37% -15.45% 6.80%
EPS Basic 5.90% 48.41% -124.11% 8.45% -53.04%
Normalized Basic EPS 5.85% 49.08% -66.18% 15.69% 20.66%
EPS Diluted 5.90% 48.41% -124.11% 8.45% -53.04%
Normalized Diluted EPS 5.85% 49.08% -66.18% 15.69% 20.66%
Average Basic Shares Outstanding 22.09% 33.18% 34.85% 20.29% 15.05%
Average Diluted Shares Outstanding 22.09% 33.18% 34.85% 20.29% 15.05%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --